A Phase Ib/II Clinical Trial of AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer
Latest Information Update: 13 Mar 2024
At a glance
- Drugs Cadonilimab (Primary) ; Carboplatin (Primary) ; Docetaxel (Primary) ; Ivonescimab (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Akeso Biopharma
Most Recent Events
- 05 Mar 2024 Planned number of patients changed from 148 to 233.
- 17 Jul 2023 Status changed from not yet recruiting to recruiting.
- 06 Jun 2023 Status changed from planning to not yet recruiting.